Trp53-Loss in Hematopoietic Stem Cells Drives the Evolutionary Process of Leukemic Transformation in a Jak2 V617F-Driven Myeloproliferative Neoplasms Mouse Model

被引：0
|
作者：
Zhang, Ranran [1 ,2 ]
Janardhanan, Yashaswini [2 ]
Haldar, Rohit [2 ]
Cooper, Leanne [2 ]
Jaquelin, Sebastien [1 ]
Straube, Jasmin [2 ]
Bywater, Megan [1 ,2 ]
Lane, Steven W. [2 ,3 ,4 ]
机构：
[1] Univ Queensland, Brisbane, Qld, Australia
[2] QIMR Berghofer Med Res Inst, Canc Program, Brisbane, Qld, Australia
[3] Royal Brisbane & Womens Hosp, Canc Care Serv, Herston, Qld, Australia
[4] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-188150
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Zinpentraxin Alfa Reduces Myelofibrosis in a JAK2-V617F Mouse Model of Myeloproliferative Neoplasms
    Rai, Shivam
    Hao-Shen, Hui
    Dirnhofer, Stefan
    Roux, Julien
    Yadav, Rajbharan
    Pfeiffer, Anamarija
    Vowinckel, Jakob
    Arjomandi, Audrey
    Higgins, Brian
    Han, Lyrialle
    Trunzer, Kerstin
    Lundberg, Pontus
    Skoda, Radek C.
    BLOOD, 2023, 142
  • [22] Myeloproliferative neoplasms can be initiated from a single hematopoietic stem cell expressing JAK2-V617F
    Lundberg, Pontus
    Takizawa, Hitoshi
    Kubovcakova, Lucia
    Guo, Guoji
    Hui Hao-Shen
    Dirnhofer, Stephan
    Orkin, Stuart H.
    Manz, Markus G.
    Skoda, Radek C.
    JOURNAL OF EXPERIMENTAL MEDICINE, 2014, 211 (11): : 2213 - 2230
  • [23] ALTERATION OF THE SELF-RENEWAL AND DIFFERENTIATION BALANCE IN SINGLE MOUSE HEMATOPOIETIC STEM CELLS BY JAK2 V617F
    Kent, David
    Li, Juan
    Tanna, Hinal
    Simons, Ben
    Green, Anthony
    EXPERIMENTAL HEMATOLOGY, 2012, 40 (08) : S112 - S112
  • [24] Polygenic Germline Risk of Common Haematological Traits Drives Clonal Selection on JAK2 V617F and Development of Myeloproliferative Neoplasms
    Nangalia, Jyoti
    Guo, Jing
    Walter, Klaudia
    Quiros, Pedro
    Gu, Muxin
    Baxter, E. Joanna
    Danesh, John
    Di Angelantonio, Emanuele
    Roberts, David
    Guglielmelli, Paola
    Harrison, Claire N.
    Godfrey, Anna L.
    Green, Anthony R.
    Vassiliou, George
    Vuckovic, Dragana
    Soranzo, Nicole
    BLOOD, 2023, 142
  • [25] ACTIVATED STAT5 AS NOVEL STEM TARGET IN JAK2 V617F POSITIVE MYELOPROLIFERATIVE NEOPLASMS (MPN)
    Hadzijusufovic, E.
    Keller, A.
    Schur, F.
    Cerny-Reiterer, S.
    Hoermann, G.
    Mayerhofer, M.
    Boudot, C.
    Gouilleux, F.
    Muellauer, L.
    Moriggl, R.
    Valent, P.
    HAEMATOLOGICA, 2015, 100 : 524 - 525
  • [26] Evaluation of a JAK2 V617F quantitative PCR to monitor residual disease post-allogeneic hematopoietic stem cell transplantation for myeloproliferative neoplasms
    Haslam, Karl
    Molloy, Karen M.
    Conneally, Eibhlin
    Langabeer, Stephen E.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2014, 52 (03) : E29 - E31
  • [27] Loss Of p53 Induces Leukemic Transformation In a Murine Model Of JAK2V617F-Induced Polycythemia Vera
    Tsuruta-Kishino, Takako
    Kataoka, Keisuke
    Kobayashi, Hiroshi
    Koya, Junji
    Narukawa, Kensuke
    Sato, Tomohiko
    Kurokawa, Mineo
    BLOOD, 2013, 122 (21)
  • [28] Mutation of the inhibitory adaptor protein LNK drives potentiated JAK-STAT signaling in patients with JAK2 V617F-negative myeloproliferative neoplasms
    Oh, Stephen T.
    Simonds, Erin F.
    Jones, Carol
    Hale, Matthew B.
    Goltsev, Yury
    Gibbs, Kenneth D.
    Merker, Jason D.
    Zehnder, James L.
    Nolan, Garry P.
    Gotlib, Jason
    CANCER RESEARCH, 2010, 70
  • [29] Expression of phosphorylated STAT5 in the putative stem cell population of JAK2 V617F transformed myeloproliferative neoplasms
    Hadzijusufovic, E.
    Keller, A.
    Schur, F.
    Cerny-Reiterer, S.
    Sadovnik, I
    Pecnard, E.
    Gouilleux, F.
    Valent, P.
    ONKOLOGIE, 2013, 36 : 288 - 288
  • [30] EXPRESSION OF PSTAT5 IN CD34+/CD38-STEM CELLS IN JAK2 V617F+MYELOPROLIFERATIVE NEOPLASMS (MPN)
    Hadzijusufovic, E.
    Schur, F.
    Cerny-Reiterer, S.
    Pecnard, E.
    Gouilleux, F.
    Valent, P.
    HAEMATOLOGICA, 2012, 97 : 45 - 45
12345